Toshiyuki Sumi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 43

Top Venues

Respirology case reports

Thoracic cancer

Journal of cancer research and clinical oncology

Cancer science

This page only lists publications with an associated author ORCID identifier.

Publications

Toshiyuki Sumi, Motoki Sekikawa, Yuta Koshino, Daiki Nagayama, Yuta Nagahisa, Keigo Matsuura, Naoki Shijubou, Koki Kamada, Keito Suzuki, Takumi Ikeda, Haruhiko Michimata, Hiroki Watanabe, Yuichi Yamada, Koichi Osuda, Yusuke Tanaka, Hirofumi Chiba
Risk factors for severe immune-related pneumonitis after nivolumab plus ipilimumab therapy for non-small cell lung cancer. Thoracic cancer (2024)
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (3) (2024)
Toshiyuki Sumi, Jun Sakakibara-Konishi, Keito Suzuki, Hirofumi Chiba
Drop finger caused by lung cancer metastasis. Respirology case reports 12 (1) (2024)
Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizumi
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer science 115 (4) (2024)
Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizumi
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer science 115 (4) (2024)
Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizumi
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer science (2024)
Toshiyuki Sumi, Keito Suzuki, Yuta Koshino, Takumi Ikeda, Yuichi Yamada, Hirofumi Chiba
Sputum colour: An indicator of Legionella pneumophila pneumonia. Respirology case reports 12 (3) (2024)
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (3) (2024)
Toshiyuki Sumi, Keito Suzuki, Kotomi Arioka, Hirofumi Chiba
Methotrexate-associated lymphoproliferative disorder of the heart. Japanese journal of clinical oncology (2024)
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (3) (2024)
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (3) (2024)
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (3) (2024)
Toshiyuki Sumi, Jun Sakakibara-Konishi, Keito Suzuki, Hirofumi Chiba
Drop finger caused by lung cancer metastasis. Respirology case reports 12 (1) (2024)
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (3) (2024)
Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizumi
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer science 115 (4) (2024)
Toshiyuki Sumi, Motoki Sekikawa, Yuta Koshino, Daiki Nagayama, Yuta Nagahisa, Keigo Matsuura, Naoki Shijubou, Koki Kamada, Keito Suzuki, Takumi Ikeda, Haruhiko Michimata, Hiroki Watanabe, Yuichi Yamada, Koichi Osuda, Yusuke Tanaka, Hirofumi Chiba
Risk factors for severe immune-related pneumonitis after nivolumab plus ipilimumab therapy for non-small cell lung cancer. Thoracic cancer 15 (20) (2024)
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of cancer research and clinical oncology 150 (3) (2024)
Toshiyuki Sumi, Motoki Sekikawa, Yuta Koshino, Daiki Nagayama, Yuta Nagahisa, Keigo Matsuura, Naoki Shijubou, Koki Kamada, Keito Suzuki, Takumi Ikeda, Haruhiko Michimata, Hiroki Watanabe, Yuichi Yamada, Koichi Osuda, Yusuke Tanaka, Hirofumi Chiba
Risk factors for severe immune-related pneumonitis after nivolumab plus ipilimumab therapy for non-small cell lung cancer. Thoracic cancer 15 (20) (2024)
Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizumi
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer science 115 (4) (2024)
Toshiyuki Sumi, Keito Suzuki, Yuta Koshino, Takumi Ikeda, Yuichi Yamada, Hirofumi Chiba
Sputum colour: An indicator of Legionella pneumophila pneumonia. Respirology case reports 12 (3) (2024)
Haruhiko Michimata, Toshiyuki Sumi, Daiki Nagayama, Yuta Koshino, Hiroki Watanabe, Yuichi Yamada, Hirofumi Chiba
Severe heart failure due to peripartum cardiomyopathy. Respirology case reports 11 (5) (2023)
Toshiyuki Sumi, Kotomi Terai, Hirofumi Chiba
Spontaneously expectorated EGFR-mutant non-small-cell lung cancer. Japanese journal of clinical oncology (2023)
Toshiyuki Sumi, Kotomi Terai, Keito Suzuki, Yuta Koshino, Takumi Ikeda, Hiroki Watanabe, Yuichi Yamada, Hirofumi Chiba
Minocycline-induced Acute Fibrinous and Organizing Pneumonia. American journal of respiratory and critical care medicine (2023)
Toshiyuki Sumi, Toshiaki Takahashi, Kotomi Terai, Hirofumi Chiba
Waldenström macroglobulinemia diagnosed by bronchoalveolar lavage. Japanese journal of clinical oncology (2023)
Naoki Shijubou, Toshiyuki Sumi, Yuichi Yamada, Hisashi Nakata, Yuji Mori, Hirofumi Chiba
Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer. Journal of cancer research and clinical oncology 148 (8) (2022)
Kazuya Takeda, Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Hiroki Watanabe, Yuichi Yamada, Hirofumi Chiba
Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 18 (1) (2022)
Hiroki Watanabe, Toshiyuki Sumi, Yoshiko Keira
Charcoal maker's pneumoconiosis. Respirology case reports 10 (10) (2022)
Daiki Nagayama, Toshiyuki Sumi, Yoshiko Keira, Yusuke Tanaka, Haruhiko Michimata, Yuta Koshino, Hiroki Watanabe, Yuichi Yamada, Hirofumi Chiba
Diffuse large B-cell lymphoma with cardiac invasion diagnosed using transesophageal ultrasound-guided bronchoscopic aspiration. Respirology case reports 10 (9) (2022)
Haruhiko Michimata, Toshiyuki Sumi, Yoshiko Keira, Daiki Nagayama, Yuta Koshino, Hiroki Watanabe, Yuichi Yamada, Yusuke Tanaka, Hirofumi Chiba
Hemothorax as a complication of transbronchial lung cryobiopsy. Respirology case reports 10 (10) (2022)
Naoki Shijubou, Toshiyuki Sumi, Koki Kamada, Yuichi Yamada, Hisashi Nakata, Hirofumi Chiba
Diffuse alveolar haemorrhage due to pheochromocytoma crisis. Respirology case reports 9 (4) (2021)
Naoki Shijubou, Toshiyuki Sumi, Koki Kamada, Takeyuki Sawai, Yuichi Yamada, Hisashi Nakata, Yuji Mori, Hirofumi Chiba
Long-term response to afatinib in an elderly patient with uncommon epidermal growth factor receptor mutation-positive lung adenocarcinoma. Thoracic cancer 12 (6) (2021)
Naoki Shijubou, Toshiyuki Sumi, Yoshiko Keira, Hideaki Shiraishi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Yuichi Yamada, Hisashi Nakata, Hirofumi Chiba
Pseudocirrhosis due to liver metastasis from lung adenocarcinoma. Thoracic cancer 12 (17) (2021)
Toshiyuki Sumi, Hirofumi Uehara, Makoto Tada, Yoshiko Keira, Koki Kamada, Naoki Shijubou, Yuichi Yamada, Hisashi Nakata, Yuji Mori, Hirofumi Chiba
Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis-associated interstitial lung disease. Respirology case reports 9 (3) (2021)
Toshiyuki Sumi, Hisashi Nakata, Yuji Mori, Hirofumi Chiba
Pseudomesotheliomatous carcinoma of lung adenocarcinoma diagnosed using transesophageal ultrasound-guided bronchoscopic aspiration. Thoracic cancer 12 (9) (2021)
Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Yuichi Yamada, Hisashi Nakata, Hirofumi Chiba
Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer-BioNTech). Thoracic cancer 12 (22) (2021)
Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Yuichi Yamada, Hisashi Nakata, Hirofumi Chiba
Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases. Respirology case reports 9 (11) (2021)
Toshiyuki Sumi, Hisashi Nakata, Hirofumi Chiba
Drastic antitumor response following administration of afatinib immediately after atezolizumab in a patient with epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer. Thoracic cancer 12 (13) (2021)
Keigo Matsuura, Makoto Tada, Toshiyuki Sumi, Koichi Osuda, Hisashi Nakata, Hirofumi Chiba
Unexpected haemorrhage from lateral thoracic artery following the removal of a pleural drainage tube. Respirology case reports 9 (12) (2021)
Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Yuichi Yamada, Hisashi Nakata, Hirofumi Chiba
Delayed local reaction at a previous injection site reaction with dupilumab. Respirology case reports 9 (10) (2021)
Toshiyuki Sumi, Koki Kamada, Naoki Shijubou, Yuichi Yamada, Hisashi Nakata, Yuji Mori, Hirofumi Chiba
Long-term response to osimertinib in elderly patients with lung adenocarcinoma harbouring de novo EGFR T790M: a case report and literature review. Respirology case reports 9 (6) (2021)
Toshiyuki Sumi, Hisashi Nakata, Yuji Mori, Hiroki Takahashi
Tegafur/gimeracil/oteracil-induced eosinophilic pneumonia. Respirology case reports 8 (4) (2020)
Toshiyuki Sumi, Hirofumi Uehara, Toshiaki Masaoka, Makoto Tada, Yoshiko Keira, Koki Kamada, Naoki Shijubou, Yuichi Yamada, Hisashi Nakata, Yuji Mori, Hirofumi Chiba
Lung adenocarcinoma with tumor resolution and dystrophic calcification after salvage surgery following immune checkpoint inhibitor therapy: A case report. Thoracic cancer 11 (11) (2020)
Toshiyuki Sumi, Takumi Ikeda, Hisashi Nakata
Asymptomatic congenital tracheal stenosis. Respirology case reports 7 (7) (2019)

Toshiyuki Sumi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Toshiyuki Sumi